Topline data were announced from two phase 3 trials evaluating ulixacaltamide in patients with essential tremor.

Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don't respond to medication and aren't candidates for surgery. Their approach, ...